ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $657,000 | -67.1% | 145,425 | -27.3% | 0.03% | -63.3% |
| Q2 2019 | $1,994,000 | -14.6% | 200,000 | 0.0% | 0.08% | -16.0% |
| Q1 2019 | $2,336,000 | -2.7% | 200,000 | 0.0% | 0.09% | -16.1% |
| Q4 2018 | $2,402,000 | -29.5% | 200,000 | 0.0% | 0.11% | -2.6% |
| Q3 2018 | $3,408,000 | -0.2% | 200,000 | 0.0% | 0.12% | -7.3% |
| Q2 2018 | $3,414,000 | – | 200,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|